High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine

Vaccine

Volumn 23, Issue 3, 2004, Pages 380-385

  McIntyre, Peter B ^a   Turnbull, Fiona M ^a   Egan, Anne Marie ^a   Burgess, Margaret A ^a   Wolter, Joanne M ^b   Schuerman, Lode M ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Antibody persistence; Diphtheria; Pertussis; Tetanus

Indexed keywords

ADT; ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADULT; AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; COHORT STUDIES; DIPHTHERIA-TETANUS VACCINE; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNIZATION, SECONDARY; MIDDLE AGED; PERTUSSIS VACCINE; SINGLE-BLIND METHOD; TIME FACTORS; VACCINATION; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 7944228643     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.05.030     Document Type: Article

References (40)

1. J.D. Cherry, L.J. Baraff, and E. Hewlett The past, present and future of pertussis. The role of adults in epidemiology and future control West J Med. 150 1989 319 328
2. W.A. Keitel, and K.M. Edwards Pertussis in adolescents and adults: time to reimmunize? Semin Respir Infect. 10 1995 51 57
3. D. Guris, P.M. Strebel, and B. Bardenheier Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults 1990-1996 Clin Infect Dis. 28 1999 1230 1237
4. P. Strebel, J. Nordin, and K. Edwards Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996 J Infect. Dis. 183 2001 1353 1359
5. R. Andrews, A. Herceg, and C. Roberts Pertussis notifications in Australia, 1991-1997 Commun Dis Intell. 21 1997 145 148
6. N.S. Crowcroft, and J. Britto Whooping cough - a continuing problem BMJ 324 2002 1537 1538
7. EA. Mortimer Jr. Pertussis and its prevention: a family affair J Infect Dis. 161 1990 473 479
8. L.A. Cattaneo, G.W. Reed, D.H. Haase, M.J. Wills, and K.M. Edwards The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years J Infect Dis. 173 1996 1256 1259
9. J.E. Hoppe Update of epidemiology, diagnosis, and treatment of pertussis Eur J Clin Microbiol Infect Dis. 15 1996 189 193
10. M.E. Pichichero, and J. Treanor Economic impact of pertussis Arch Pediatr Adolesc Med. 151 1997 35 40
11. Q. He, M.K. Viljanen, H. Arvilommi, B. Aittanen, and J. Mertsola Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunised population JAMA 280 1998 635 637
12. L. Lee, and M. Pichichero Costs of illness due to Bordetella pertussis in families Arch Fam Med. 9 2000 989 996
13. P.F. Thomas, P.B. McIntyre, and B.B. Jalaludin Survey of pertussis morbidity in adults in western Sydney Med J Aust. 173 2000 74 76
14. E. Miller, D.M. Fleming, Ashworth LAE, D.A. Mabbett, J.E. Vurdien, and T.S.J. Elliot Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham Commun Dis Public Health 3 2000 132 134
15. S. Baron, E. Njamkepo, and E. Grimprel Epidemiology of pertussis in French hospitals in 1993 and 1994: 30 years after a routine use of vaccination Pediatr Infect Dis J 17 1998 412 418
16. J.D. Nelson The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection Am J Dis Child. 132 1978 371 373
17. T. Aoyama, M. Harashima, K. Nishimura, and Y. Saito Outbreak of pertussis in highly immunized adolescents and its secondary spread to their families Acta Paediatr Jpn. 37 1995 321 324
18. C.H. Wirsing von König, S. Postels-Multani, H.L. Bock, and H.J. Schmitt Pertussis in adults: frequency of transmission after household exposure Lancet. 346 1995 1326 1329
19. C. Smith, and H. Vyas Early infantile pertussis; increasingly prevalent and potentially fatal Eur J Pediatr. 159 2000 898 900
20. Pertussis deaths - United States, 2000 MMWR 51 2002 616 618.
21. J.E. Hoppe Neonatal pertussis Pediatr Infect Dis J 19 2000 244 247
22. M. Campins-Marti, H.K. Cheng, and K. Forsyth International Consensus Group on Pertussis Immunisation. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration Vaccine 20 2001 641 646
23. M. Van der Wielen, P. Van Damme, E. Joossens, G. François, F. Meurice, and A. Ramalho A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults Vaccine 18 2000 2075 2082
24. F.M. Turnbull, T.C. Heath, B.B. Jalaludin, M.A. Burgess, and A.C. Ramalho A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults Vaccine. 19 2000 628 636
25. S.G.F. Wassilak, W.A. Orenstein, and R.W. Sutter Tetanus toxoid S.A. Plotkin E.A. Mortimer Vaccines 2nd ed. 1994 WB Saunders Company Philadelphia 57 90
26. S. Salmaso, P. Mastrantonio, A. Tozzi The Stage III Working Group Sustained efficacy during the first 6 years of life of three-component acellular pertussis vaccines administered in infancy: the Italian experience Pediatrics 108 2001 e81
27. N.N. Minh, Q. He, and A. Ramalho Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents Pediatrics 104 1999 e70
28. A. Di Tommaso, M. Bartalini, S. Peppoloni, A. Podda, R. Rappuoli, and M.T. De Magistris Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults Vaccine 15 1997 1218 1224
29. M.E. Melville-Smith, V.A. Seagroatt, and J.T. Watkins A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera J Biol Stand 11 1983 137 144
30. M. Melville-Smith, and A. Balfour Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test J. Med. Microbiol. 25 1988 279 283
31. K. Miyamura, S. Nishio, A. Ito, R. Murata, and R. Kono Micro cell culture method for determination of diphtheria toxin and antitoxin concentrations using VERO cells Part I. Studies on factors affecting the toxin and antitoxin titration J Biol Stand 2 1974 189 201
32. K. Miyamura, S. Nishio, A. Ito, R. Murata, and R. Kono Micro cell culture method for determination of diphtheria toxin and antitoxin concentrations using VERO cells Part II. Comparison with rabbit skin method and practical application for seroepidemiological studies J Biol Stand 2 1974 203 209
33. J. Ward Acellular pertussis vaccine in adolescents and adults Proceedings of the 41st Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) Chicago 2001 520
34. H.-J. Schmitt, A. Schuind, and M. Knuf Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants J Pediatr. 129 1996 695 701
35. H.-J. Schmitt, C.H. Wirsing von König, and A. Neiss Efficacy of acellular pertussis vaccine in early childhood after household exposure JAMA 275 1996 37 41
36. Food and Drug Administration Center for Biologics Evaluation and Research Proceedings of a Vaccines and Related Biological Products Advisory Committee Open Session on Adult Pertussis (Day 1), 5 June 1997, Bethesda, Maryland 1997 153 295
37. M. Van der Wielen, P. Van Damme, K. Van Herck, S. Schlegel-Haueter, and C.-A. Siegrist Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium) Vaccine 21 2003 2412 2417
38. P. Olin, H.O. Hallander, L. Gustafsson, E. Reizenstein, and J. Storsaeter How to make sense of pertussis immunogenicity data CID 33 Supp 4 2001 S288 S291
39. National Health and Medical Research Council The Australian Immunisation Handbook 7th ed. 2000. Australian Government Publishing Service Canberra
40. National Health and Medical Research Council. Media Release 19 September 2003. http://www.nhmrc.gov.au/media/rel2003/imhand.htm.